NASDAQ: SPRY - ARS Pharmaceuticals, Inc.

Yield per half year: -7.75%
Dividend yield: 0.00%
Sector: Healthcare

Share chart ARS Pharmaceuticals, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc., биофармацевтическая компания, разрабатывает методы лечения пациентов и родителей, страдающих тяжелыми аллергическими реакциями. Компания разрабатывает neffy, безыгольный интраназальный назальный спрей с низкой дозой адреналина для пациентов и лиц, осуществляющих уход за ними, с аллергическими реакциями I типа, включая анафилаксию. Компания была основана в 2015 году и базируется в Сан-Диего, штат Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2020-12-04
ISIN US82835W1080
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://ars-pharma.com
Цена ао 12.6
Change price per day: 0% (14.05)
Change price per week: +9.51% (12.83)
Change price per month: +17.57% (11.95)
Change price per 3 month: +24.78% (11.26)
Change price per half year: -7.75% (15.23)
Change price per year: +52.06% (9.24)
Change price per 3 year: +353.23% (3.1)
Change price per year to date: +28.19% (10.96)
All parameters

Underestimation

Title Value Grade
P/S 12.12 1
P/BV 4.21 4
P/E 135.06 1
EV/EBITDA -333.91 0
Total: 3.63

Efficiency

Title Value Grade
ROA, % 2.74 1
ROE, % 3.28 1
Total: 0.8333

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0136 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % 400.84 10
Yield Ebitda, % 565.87 10
Yield EPS, % -541.31 0
Total: 5.2
More

Institutions Volume Share, %
Deerfield Management Company, L.P. (Series C) 11077927 11.69
Orbimed Advisors LLC. 8740887 9.22
FMR, LLC 5088253 5.37
SR One Capital Management, LP 4012903 4.23
Rubric Capital Management LP 3480712 3.67
RA Capital Management, L.P. 3009678 3.18
K2 Principal Fund, L.P. 2686490 2.83
Baker Brothers Advisors, LLC 2006451 2.12
Nextech Invest Ag 1910029 2.02
Vanguard Group Inc 1697637 1.79

ETFShare, %Profitability for 1 year, %Dividends, %
Future Tech ETF 0.13757 426.34 0.8416
Principal Healthcare Innovators ETF 0.13757 618.5 0.8416
0.14522.420.84



Head Job title Payment Year of birth
Mr. Richard Lowenthal M.B.A., M.S., MSMSEL Founder, President, CEO & Director 908.83k 1966 (59 years)
Dr. Sarina Tanimoto M.B.A., M.D. Co-Founder & Chief Medical Officer 748.97k 1969 (56 years)
Mr. Eric Karas Chief Commercial Officer 618.61k 1973 (52 years)
Dr. Robert Bell Ph.D. Co-Founder & Chief Science Officer N/A
Ms. Kathleen D. Scott CPA Chief Financial Officer N/A
Mr. Brian T. Dorsey M.S. Chief Operations Officer N/A 1969 (56 years)
Mr. Alexander A. Fitzpatrick Esq. Chief Legal Officer & Secretary N/A 1967 (58 years)
Mr. Daniel Relovsky Senior Vice President of Marketing N/A
Mr. Justin Chakma Chief Business Officer & Secretary N/A 1990 (35 years)
Mr. Harris Kaplan M.B.A. Executive Vice President of Commercial Strategy N/A 1952 (73 years)

Address: United States, San Diego. CA, 11682 El Camino Real - open in Google maps, open in Yandex maps
Website: https://ars-pharma.com